There is evidence to indicate that full adrenergic blockade by carvedilol improves survival and cardiovascular outcome in patients with heart failure compared with metoprolol treatment ...

Maack et al. [70] recently reported on switching between β blockers (metoprolol and carvedilol) in 68 patients treated with either agent for 1 year who had improved in terms of LVEF and NYHA class.

The β blockers carvedilol, metoprolol, and bisoprolol prolong survival in patients with chronic heart failure. Although some studies suggest that carvedilol may be superior to metoprolol in ...